|
시장보고서
상품코드
1789371
세계의 점안제 시장 : 유형별, 치료 용도별, 약제 클래스별, 방부제별, 유형별, 제형별, 점도별, 유통 채널별, 최종사용자별, 지역별Eye Drops Market, By Type, By Therapeutic Application, By Drug Class, By Preservative Status, By Type, By Formulation, By Viscosity, By Distribution Channel, By End User, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
점안제 시장은 2025년에 68억 1,000만 달러, 2032년에는 92억 7,000만 달러에 이르고, 2025-2032년 연평균 복합 성장률(CAGR)은 4.2%를 나타낼 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 68억 1,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 CAGR(2025-2032년) | 4.20% | 예측 금액(2032년) | 92억 7,000만 달러 |
세계 점안제 시장은 안과 의약품 산업의 중요한 부문으로, 다양한 안과 질환을 치료하고 안구 건강을 최적으로 유지하기 위해 고안된 다양한 치료 및 진단 솔루션을 포함하고 있습니다.
점안액으로도 알려진 점안제는 녹내장, 안구건조증, 알레르기성 결막염, 세균 및 바이러스 감염, 염증 관련 질환 등을 대상으로 하는 약물의 주요 전달 메커니즘으로 작용합니다. 이 시장에는 처방약, 일반의약품, 인공눈물, 항히스타민제, 항생제, 항염증제, 녹내장 치료제 등 특수 제제가 포함됩니다.
인구 고령화, 장시간 스크린 사용, 환경오염물질, 생활습관 변화 등의 요인으로 인해 눈 관련 질환의 유병률이 증가함에 따라 효과적인 안과 치료에 대한 수요는 전 세계적으로 지속적으로 증가하고 있습니다. 시장의 성장 궤적은 약물 전달 시스템의 기술적 진보, 혁신적인 방부제 없는 제형, 환자의 순응도와 치료 효과를 향상시키는 서방형 메커니즘의 개발로 더욱 뒷받침되고 있습니다.
시장 역학
세계 점안제 시장은 국제 시장에서의 확장을 촉진하는 몇 가지 주요 요인에 의해 뒷받침되고 있습니다. 특히 녹내장, 황반변성, 당뇨망막병증 등 노화와 관련된 질환은 고령화가 진행됨에 따라 전 세계적으로 수백만 명이 앓고 있습니다. 또한, 디지털 기기의 사용 빈도가 급격히 증가함에 따라 컴퓨터 시각 증후군과 안구건조증 증상이 급증하여 윤활 점안제 및 치료용 점안제에 대한 수요가 크게 증가하고 있습니다.
무방부제 제제, 서방형 메커니즘 등 약물 전달 시스템의 혁신은 환자의 순응도와 치료 결과를 개선하여 시장 성장을 더욱 촉진하고 있습니다. 그러나 시장 확대 가능성을 가로막는 큰 요인도 있습니다. 안과용 제품에 대한 엄격한 규제 요건으로 인해 대규모 임상시험 및 승인 절차가 필요하며, 이로 인해 개발 기간이 길어지고 막대한 재정적 투자가 필요하기 때문에 중소 제조업체에게는 걸림돌이 될 수 있습니다.
또한, 안약에 함유된 특정 방부제로 인한 오염 및 부작용의 위험은 환자와 의료진 사이에서 안전에 대한 우려를 높이고 있습니다. 또한, 대형 브랜드 제품의 특허 만료도 경쟁 압력을 강화하여 제약사의 수익률을 떨어뜨리고 있습니다. 이러한 도전에도 불구하고, 시장에는 성장과 혁신의 큰 기회가 있습니다. 또한, 아시아태평양과 라틴아메리카의 신흥 시장은 의료 인프라의 개선과 눈 건강에 대한 인식이 높아짐에 따라 미개발된 잠재력을 가지고 있습니다.
본 보고서의 주요 특징
- 세계의 점안제 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측기간(2025-2032년) 시장 규모와 CAGR을 조사하여 전해드립니다.
- 또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 세계 점안제 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 작성되었습니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- '세계 점안제 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 점안제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
- 분석 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- PORTER 분석
- 기업인수합병(M&A) 시나리오
- 업계 동향
제4장 세계의 점안제 시장 : 유형별(2020-2032년)
- 처방전 점안제
- 시판 점안제
제5장 세계의 점안제 시장, 치료 용도별(2020-2032년)
- 안구건조증(DED) 관리
- 알레르기성 결막염 치료
- 녹내장 및 고안압증
- 눈감염증 치료(세균성, 바이러스성, 진균성)
- 염증 또는 수술후 케어
- 동공이 확장되어 있는 상태 또는 모양체 마비
- 진단용 염료 용액
- 수술후 케어(점안 마취)
- 포도막염
- 기타 망막 질환
제6장 세계의 점안제 시장 : 약제 클래스별(2020-2032년)
- 윤활제 및 완화제
- 항히스타민제
- 비만세포 안정제
- 코르티코스테로이드
- 비스테로이드성 항염증제(NSAID)
- 프로스타글란딘 유사체
- 베타 차단제
- 알파 작용제
- 탄산탈수효소 억제제
- 항생제
- 항바이러스제
- 항진균제
- 혈관수축제
- 복합제형 약물
제7장 세계의 점안제 시장 : 방부제별(2020-2032년)
- 방부제 첨가 점안제
- 무방부제 점안제
제8장 세계의 점안제 시장 : 유형별(2020-2032년)
- 브랜드
- 제네릭 의약품
제9장 세계의 점안제 시장 : 제형별(2020-2032년)
- 용액
- 현탁액
- 유제
제10장 세계의 점안제 시장 : 점도별(2020-2032년)
- 저점도
- 중점도
- 고점도
제11장 세계의 점안제 시장 : 유통 채널별(2020-2032년)
- 병원 약국
- 소매 약국
- 온라인 약국
제12장 세계의 점안제 시장 : 최종사용자별(2020-2032년)
- 병원
- 안과 클리닉
- 기타(외래수술센터(ASC))
제13장 세계의 점안제 시장 : 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙아프리카
제14장 경쟁 구도
- Alcon
- AbbVie Inc(Allergan)
- Bausch Health Companies Inc
- Johnson & Johnson Vision
- Santen Pharmaceutical Co Ltd
- Pfizer Inc
- Bayer AG
- Sun Pharmaceutical Industries Ltd
- Otsuka Pharmaceutical Co Ltd
- Rohto Pharmaceutical Co Ltd
- Thea Pharma Inc
- Similasan Corporation
- Akorn Operating Company LLC
- Prestige Consumer Healthcare Inc
- Jamjoom Pharmaceuticals
제15장 애널리스트의 제안
- 'Wheel of Fortune'
- 애널리스트의 견해
- Coherent Opportunity Map(COM)
제16장 참고 문헌과 조사 방법
- 참고 문헌
- 분석 방법
- Coherent Market Insights에 대해
Eye Drops Market is estimated to be valued at USD 6.81 Bn in 2025 and is expected to reach USD 9.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.2% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 6.81 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 4.20% | 2032 Value Projection: | USD 9.27 Bn |
The global eye drops market represents a critical segment of the ophthalmic pharmaceutical industry, encompassing a diverse range of therapeutic and diagnostic solutions designed to address various ocular conditions and maintain optimal eye health.
Eye drops, also known as ophthalmic solutions, serve as the primary delivery mechanism for medications targeting conditions such as glaucoma, dry eye syndrome, allergic conjunctivitis, bacterial and viral infections, and inflammation-related disorders. The market encompasses prescription medications, over-the-counter solutions, and specialized formulations including artificial tears, antihistamines, antibiotics, anti-inflammatory agents, and glaucoma medications.
With the increasing prevalence of eye-related disorders driven by factors such as aging populations, prolonged screen time, environmental pollutants, and lifestyle changes, the demand for effective ophthalmic treatments continues to escalate globally. The market's growth trajectory is further supported by technological advancements in drug delivery systems, innovative preservative-free formulations, and the development of sustained-release mechanisms that enhance patient compliance and therapeutic efficacy.
Market Dynamics
The global eye drops market is propelled by several key drivers that collectively fuel its expansion across international markets. The primary growth driver stems from the rising prevalence of ocular disorders, particularly age-related conditions such as glaucoma, macular degeneration, and diabetic retinopathy, which affect millions of individuals worldwide as populations continue to age. Additionally, the exponential increase in digital device usage has led to a surge in computer vision syndrome and dry eye conditions, creating substantial demand for lubricating and therapeutic eye drops.
Technological innovations in drug delivery systems, including preservative-free formulations and extended-release mechanisms, enhance patient compliance and treatment outcomes, further driving market growth. However, the market faces significant restraints that challenge its expansion potential. Stringent regulatory requirements for ophthalmic products necessitate extensive clinical trials and approval processes, resulting in lengthy development timelines and substantial financial investments that may deter smaller manufacturers.
Furthermore, the risk of contamination and adverse reactions associated with certain preservatives in eye drops raises safety concerns among patients and healthcare providers. Patent expirations of major branded products also intensify competitive pressures and reduce profit margins for pharmaceutical companies. Despite these challenges, the market presents substantial opportunities for growth and innovation. The expanding geriatric population globally creates a sustained demand for ophthalmic treatments, while emerging markets in Asia Pacific and Latin America offer untapped potential due to improving healthcare infrastructure and rising awareness about eye health.
Key Features of the Study
- This report provides in-depth analysis of the global eye drops market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global eye drops market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include major pharmaceutical manufacturers, Alcon, AbbVie Inc (Allergan), Bausch Health Companies Inc, Johnson & Johnson Vision, Santen Pharmaceutical Co Ltd, Pfizer Inc, Bayer AG, Sun Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Rohto Pharmaceutical Co Ltd, Thea Pharma Inc, Similasan Corporation, Akorn Operating Company LLC, Prestige Consumer Healthcare Inc, and Jamjoom Pharmaceuticals.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global eye drops market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global eye drops market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Prescription Eye Drops
- Over-the-Counter (OTC) Eye Drops
- Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
- Dry Eye Disease (DED) Management
- Allergic Conjunctivitis Treatment
- Glaucoma & Ocular Hypertension
- Eye Infection Treatment (Bacterial, Viral, Fungal)
- Inflammation or Post-Surgical Care
- Mydriasis or Cycloplegia
- Diagnostic Dye Solutions
- Post-Operative Care (Anesthetic Drops)
- Uveitis
- Other Retinal Disorders
- Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Lubricants and Emollients
- Antihistamines
- Mast Cell Stabilizers
- Corticosteroids
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Prostaglandin Analogs
- Beta-Blockers
- Alpha Agonists
- Carbonic Anhydrase Inhibitors
- Antibiotics
- Antivirals
- Antifungals
- Vasoconstrictors
- Combination Drugs
- Preservative Status Insights (Revenue, USD Bn, 2020 - 2032)
- Preserved Eye Drops
- Preservative-Free Eye Drops
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Brand
- Generics
- Formulation Insights (Revenue, USD Bn, 2020 - 2032)
- Solution
- Suspension
- Emulsion
- Viscosity Insights (Revenue, USD Bn, 2020 - 2032)
- Low Viscosity
- Medium Viscosity
- High Viscosity
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Ophthalmology Clinics
- Others (Ambulatory Surgery Centers)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Alcon
- AbbVie Inc (Allergan)
- Bausch Health Companies Inc
- Johnson & Johnson Vision
- Santen Pharmaceutical Co Ltd
- Pfizer Inc
- Bayer AG
- Sun Pharmaceutical Industries Ltd
- Otsuka Pharmaceutical Co Ltd
- Rohto Pharmaceutical Co Ltd
- Thea Pharma Inc
- Similasan Corporation
- Akorn Operating Company LLC
- Prestige Consumer Healthcare Inc
- Jamjoom Pharmaceuticals
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Eye Drops Market, By Type
- Global Eye Drops Market, By Therapeutic Application
- Global Eye Drops Market, By Drug Class
- Global Eye Drops Market, By Preservative Status
- Global Eye Drops Market, By Type
- Global Eye Drops Market, By Formulation
- Global Eye Drops Market, By Viscosity
- Global Eye Drops Market, By Distribution Channel
- Global Eye Drops Market, By End User
- Global Eye Drops Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Eye Drops Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Prescription Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Over-the-Counter (OTC) Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Eye Drops Market, By Therapeutic Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Dry Eye Disease (DED) Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Allergic Conjunctivitis Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Glaucoma & Ocular Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Eye Infection Treatment (Bacterial, Viral, Fungal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Inflammation or Post-Surgical Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Mydriasis or Cycloplegia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Dye Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Post-Operative Care (Anesthetic Drops)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Uveitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other Retinal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Eye Drops Market, By Drug Class, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Lubricants and Emollients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antihistamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Mast Cell Stabilizers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prostaglandin Analogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Beta-Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Alpha Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Carbonic Anhydrase Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antifungals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Vasoconstrictors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Combination Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Eye Drops Market, By Preservative Status, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Preserved Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Preservative-Free Eye Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Eye Drops Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Brand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Generics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Eye Drops Market, By Formulation, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Suspension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Emulsion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Eye Drops Market, By Viscosity, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Low Viscosity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medium Viscosity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- High Viscosity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Eye Drops Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12. Global Eye Drops Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ophthalmology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Ambulatory Surgery Centers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
13. Global Eye Drops Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
14. Competitive Landscape
- Alcon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc (Allergan)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bausch Health Companies Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Vision
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Santen Pharmaceutical Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Otsuka Pharmaceutical Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Rohto Pharmaceutical Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thea Pharma Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Similasan Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Akorn Operating Company LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Prestige Consumer Healthcare Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jamjoom Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
15. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
16. References and Research Methodology
- References
- Research Methodology
- About us
샘플 요청 목록